Injected drug reduces risk of fracture among women with osteoporosis
Wednesday, August 17, 2016 - 09:02
in Health & Medicine
Among postmenopausal women with osteoporosis at risk of fracture, daily injection of the drug abaloparatide for 18 months significantly reduced the risk of new vertebral and nonvertebral fractures compared with placebo, according to a study.